ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000029 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
6,821
Total Value
$695,201.15
P&L
+inf% (+$1,429,426.43)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP Chief R&D | Common Stock | โ | Feb 12, 2026 | Grant/Award | 4,579 | $0.00 | $0.00 | 27,090 | Direct | โ | View Details | |
EVP Chief R&D | Common Stock | โ | Feb 13, 2026 | Sale | 2,242 | $310.08 | $695,201.15 | 24,848 | Direct | โ | View Details |